Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis

Gabriela B. Thoennissen,Dennis Görlich,Ulrike Bacher,Thomas Aufenberg,Anne-Christin Hüsken,Anna Hansmeier,Georg Evers,Jan-Henrik Mikesch,Fleur Fritz,Carsten Bokemeyer,Carsten Müller-Tidow,Matthias Stelljes,Rolf M. Mesters,Utz Krug,Martin Kropff,Nils H. Thoennissen,Wolfgang E. Berdel

Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis

2017

Gabriela B. Thoennissen
Dennis Görlich
Ulrike Bacher
Thomas Aufenberg
Anne-Christin Hüsken
Anna Hansmeier
Georg Evers
Jan-Henrik Mikesch
Fleur Fritz
Carsten Bokemeyer
Carsten Müller-Tidow
Matthias Stelljes
Rolf M. Mesters
Utz Krug
Martin Kropff
Nils H. Thoennissen
Wolfgang E. Berdel

Within this retrospective single-center study, we analyzed the survival of 320 multiple myeloma (MM) patients receiving melphalan high-dose chemotherapy (HDCT) and either single ( n

Keywords:

Immunology
Medicine
Melphalan
Autologous stem-cell transplantation
Chemotherapy
Multiple myeloma
Internal medicine
Combined Modality Therapy
Oncology
Induction chemotherapy
Retrospective cohort study
Single Center

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations